Aethlon Medical Reaches Analyst Target Price
June 10, 2021 at 08:16 AM EDT
In recent trading, shares of Aethlon Medical Inc (AEMD) have crossed above the average analyst 12-month target price of $6.33, changing hands for $10.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..